City Therapeutics, Inc., a biopharmaceutical company leading the future of RNA interference (RNAi)-based medicine, today announced the appointment of Andrew "Andy" Orth as chief executive officer and ...
Bio-Techne Corporation today announced that it prevailed on another claim that Miltenyi Biotec B.V. & Co. KG commercialized antibodies developed based on information obtained by reverse engineering ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback